Medical Information Only: This medication is not sold on this site. The information provided is for reference purposes only. Please consult your local physician or pharmacist for treatment.

Limican: Full Drug Profile

Medically reviewed by Min Clinic Staff | Updated: January 2026

Limican - General Information

Limican is a dopamine antagonist with prokinetic and antiemetic effects used in the treatment of nausea and vomiting, including postoperative nausea and vomiting.

 

Pharmacology of Limican

Not Available

 

Additional information about Limican

Limican Indication: Not Available Mechanism Of Action: Not Available Drug Interactions: Not Available Food Interactions: Not Available Generic Name: Alizapride Synonyms: Alizaprida [inn-spanish]; Alizapridum [inn-latin] Drug Category: Not Available Drug Type: Small Molecule; Approved Other Brand Names containing Alizapride: Limican; Liticum; Absorption: Not Available Toxicity (Overdose): Not Available Protein Binding: Not Available Biotransformation: Not Available Half Life: Not Available Dosage Forms of Limican: Not Available Chemical IUPAC Name: 6-methoxy-N-[(1-prop-2-enylpyrrolidin-2-yl)methyl]-2H-benzotriazole-5-carboxamide Chemical Formula: C16H21N5O2 Alizapride on Wikipedia: https://en.wikipedia.org/wiki/Alizapride Organisms Affected: Not Available